cytidine has been researched along with Cancer of Ovary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgel, S; Carter, J; Collins, JM; Georgius, K; Hoffman, SN; Hollingshead, MG; Huang, G; Kunkel, MW; Lopez, OD; Morris, J; Rudchenko, V; Stotler, H; Teicher, BA; Wishka, DG | 1 |
| Giuashvili, S; Königsrainer, A; Reymond, M; Sautkin, I; Schott, TC; Struller, F; Weinreich, J | 1 |
| Kim, DJ; Lee, YB; Peters, GJ; Sarkisjan, D; Smit, E; van den Berg, J | 1 |
| Balch, C; Craft, T; Huang, TH; Nephew, KP; Skalnik, DG; Yan, P; Young, S | 1 |
| Brachetti, A; Leonhardt, A; Limburg, H; Osswald, H; Schmähl, D | 1 |
5 other study(ies) available for cytidine and Cancer of Ovary
| Article | Year |
|---|---|
F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd.
Topics: Animals; Cell Culture Techniques; Cytidine; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
Topics: Adult; Aged; Apoptosis; Cell Proliferation; Cisplatin; Colonic Neoplasms; Cytidine; Cytostatic Agents; Deoxyuridine; Doxorubicin; Female; Humans; Hyperthermia, Induced; In Vitro Techniques; Middle Aged; Ovarian Neoplasms; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured | 2019 |
The radiosensitizing effect of fluorocyclopentenyl-cytosine (RX-3117) in ovarian and lung cancer cell lines.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cytidine; DNA Damage; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Radiation-Sensitizing Agents | 2016 |
Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Cytidine; Decitabine; DNA Methylation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Ovarian Neoplasms | 2005 |
[Clinical experiences with a combination therapy of metastasising genital and mammary carcinomas (author's transl)].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Cyclophosphamide; Cytidine; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Podophyllotoxin; Postoperative Care; Prognosis; Remission, Spontaneous; Thymidine; Uterine Cervical Neoplasms; Vinblastine | 1974 |